USD 26.59
(-8.63%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 60.43 Million USD | 22.77% |
2022 | 49.22 Million USD | -48.05% |
2021 | 94.76 Million USD | 16.36% |
2020 | 81.44 Million USD | 61.87% |
2019 | 50.31 Million USD | -74.07% |
2018 | 194.07 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | -100.0% |
2014 | 7.41 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 10.75 Million USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | -100.0% |
2006 | 2000.00 USD | -100.0% |
2005 | 175 Million USD | -0.01% |
2004 | 175.01 Million USD | -0.01% |
2003 | 175.02 Million USD | -0.09% |
2002 | 175.17 Million USD | 0.08% |
2001 | 175.03 Million USD | 61967.73% |
2000 | 282 Thousand USD | -64.75% |
1999 | 800 Thousand USD | 700.0% |
1998 | 100 Thousand USD | -50.0% |
1997 | 200 Thousand USD | -66.67% |
1996 | 600 Thousand USD | 20.0% |
1995 | 500 Thousand USD | -84.38% |
1994 | 3.2 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 60.65 Million USD | 0.0% |
2024 Q2 | 63.37 Million USD | -100.0% |
2024 Q1 | 66.47 Million USD | 0.0% |
2023 Q1 | 52.49 Million USD | 6.64% |
2023 Q4 | 60.43 Million USD | -2.21% |
2023 Q2 | 57.13 Million USD | 8.84% |
2023 Q3 | 61.79 Million USD | 8.16% |
2023 FY | 60.43 Million USD | 22.77% |
2022 Q4 | 49.22 Million USD | 5.37% |
2022 FY | 49.22 Million USD | -48.05% |
2022 Q1 | 93.5 Million USD | -1.33% |
2022 Q2 | 48.69 Million USD | -47.92% |
2022 Q3 | 46.71 Million USD | -4.06% |
2021 Q4 | 94.76 Million USD | 0.08% |
2021 Q1 | 83.8 Million USD | 2.9% |
2021 FY | 94.76 Million USD | 16.36% |
2021 Q2 | 82.4 Million USD | -1.67% |
2021 Q3 | 94.68 Million USD | 14.91% |
2020 Q1 | 70.44 Million USD | 40.01% |
2020 Q2 | 77.18 Million USD | 9.57% |
2020 Q3 | 78.84 Million USD | 2.15% |
2020 Q4 | 81.44 Million USD | 3.3% |
2020 FY | 81.44 Million USD | 61.87% |
2019 Q1 | 531.28 Million USD | 173.76% |
2019 Q4 | 50.31 Million USD | -90.59% |
2019 FY | 50.31 Million USD | -74.07% |
2019 Q3 | 534.74 Million USD | -0.12% |
2019 Q2 | 535.38 Million USD | 0.77% |
2018 Q1 | 195.27 Million USD | 0.0% |
2018 FY | 194.07 Million USD | 0.0% |
2018 Q4 | 194.07 Million USD | -0.21% |
2018 Q3 | 194.47 Million USD | -0.21% |
2018 Q2 | 194.87 Million USD | -0.21% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q1 | 7.29 Million USD | -1.63% |
2015 Q2 | 7.17 Million USD | -1.69% |
2015 Q3 | 7.04 Million USD | -1.73% |
2015 Q4 | - USD | -100.0% |
2015 FY | - USD | -100.0% |
2014 FY | 7.41 Million USD | 0.0% |
2014 Q4 | 7.41 Million USD | -1.59% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | 7.65 Million USD | 0.0% |
2014 Q3 | 7.53 Million USD | -1.55% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q1 | - USD | -100.0% |
2010 FY | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | -100.0% |
2010 Q2 | 11.09 Million USD | 0.0% |
2009 FY | 10.75 Million USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | 10.75 Million USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q2 | - USD | -100.0% |
2007 Q1 | 9000.00 USD | 350.0% |
2007 FY | - USD | -100.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 Q4 | 2000.00 USD | -75.0% |
2006 Q2 | 3000.00 USD | -100.0% |
2006 Q1 | 175 Million USD | -0.0% |
2006 FY | 2000.00 USD | -100.0% |
2006 Q3 | 8000.00 USD | 166.67% |
2005 Q1 | 175.01 Million USD | -0.0% |
2005 Q2 | 175 Million USD | -0.01% |
2005 Q3 | 175 Million USD | 0.0% |
2005 FY | 175 Million USD | -0.01% |
2005 Q4 | 175 Million USD | -0.0% |
2004 Q2 | 175.02 Million USD | -0.0% |
2004 Q4 | 175.01 Million USD | -0.0% |
2004 Q3 | 175.01 Million USD | -0.0% |
2004 FY | 175.01 Million USD | -0.01% |
2004 Q1 | 175.02 Million USD | -0.0% |
2003 Q3 | 175.06 Million USD | -0.01% |
2003 FY | 175.02 Million USD | -0.09% |
2003 Q4 | 175.02 Million USD | -0.02% |
2003 Q2 | 175.08 Million USD | 0.02% |
2003 Q1 | 175.05 Million USD | -0.07% |
2002 Q2 | 177.32 Million USD | 1.01% |
2002 Q1 | 175.56 Million USD | 0.3% |
2002 Q3 | 175.61 Million USD | -0.96% |
2002 Q4 | 175.17 Million USD | -0.25% |
2002 FY | 175.17 Million USD | 0.08% |
2001 Q3 | 175.03 Million USD | 0.0% |
2001 Q4 | 175.03 Million USD | -0.0% |
2001 Q2 | - USD | -100.0% |
2001 Q1 | 79 Thousand USD | -71.99% |
2001 FY | 175.03 Million USD | 61967.73% |
2000 Q2 | 562 Thousand USD | -19.71% |
2000 FY | 282 Thousand USD | -64.75% |
2000 Q1 | 700 Thousand USD | -12.5% |
2000 Q4 | 282 Thousand USD | -35.47% |
2000 Q3 | 437 Thousand USD | -22.24% |
1999 Q2 | - USD | 0.0% |
1999 Q1 | - USD | -100.0% |
1999 FY | 800 Thousand USD | 700.0% |
1999 Q4 | 800 Thousand USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1998 Q4 | 100 Thousand USD | 0.0% |
1998 Q1 | 100 Thousand USD | -50.0% |
1998 FY | 100 Thousand USD | -50.0% |
1998 Q2 | 100 Thousand USD | 0.0% |
1998 Q3 | 100 Thousand USD | 0.0% |
1997 Q3 | 600 Thousand USD | -14.29% |
1997 Q2 | 700 Thousand USD | 16.67% |
1997 FY | 200 Thousand USD | -66.67% |
1997 Q1 | 600 Thousand USD | 0.0% |
1997 Q4 | 200 Thousand USD | -66.67% |
1996 FY | 600 Thousand USD | 20.0% |
1996 Q2 | 800 Thousand USD | 0.0% |
1996 Q4 | 600 Thousand USD | -25.0% |
1996 Q3 | 800 Thousand USD | 0.0% |
1995 Q4 | 500 Thousand USD | 0.0% |
1995 FY | 500 Thousand USD | -84.38% |
1994 FY | 3.2 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 19.691% |
AngioDynamics, Inc. | 3.93 Million USD | -1434.298% |
AtriCure, Inc. | 60.59 Million USD | 0.259% |
Avinger, Inc. | - USD | -Infinity% |
BioLife Solutions, Inc. | 18.31 Million USD | -230.053% |
The Cooper Companies, Inc. | 2.52 Billion USD | 97.605% |
Daxor Corporation | 755.65 Thousand USD | -7897.787% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | -1150.745% |
Femasys Inc. | 4.25 Million USD | -1319.292% |
GlucoTrack, Inc. | 196 Thousand USD | -30734.694% |
Harvard Bioscience, Inc. | 30.7 Million USD | -96.834% |
Hologic, Inc. | 2.49 Billion USD | 97.58% |
ICU Medical, Inc. | 1.57 Billion USD | 96.17% |
Intuitive Surgical, Inc. | -82.1 Million USD | 173.613% |
KORU Medical Systems, Inc. | 3.65 Million USD | -1554.456% |
LeMaitre Vascular, Inc. | 16.62 Million USD | -263.547% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 93.067% |
Microbot Medical Inc. | 40 Thousand USD | -150990.0% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -1316014.983% |
Merit Medical Systems, Inc. | 823.01 Million USD | 92.657% |
Nephros, Inc. | 1.39 Million USD | -4247.914% |
NovoCure Limited | 596.24 Million USD | 89.864% |
NEXGEL, Inc. | 513 Thousand USD | -11680.897% |
NEXGEL, Inc. | 513 Thousand USD | -11680.897% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 10.497% |
OraSure Technologies, Inc. | 11.38 Million USD | -430.699% |
Pro-Dex, Inc. | 7.53 Million USD | -701.964% |
Pulse Biosciences, Inc. | 8.08 Million USD | -647.415% |
Predictive Oncology Inc. | 2.18 Million USD | -2660.922% |
Precision Optics Corporation, Inc. | 1.93 Million USD | -3018.521% |
QuidelOrtho Corporation | 2.27 Billion USD | 97.343% |
Repligen Corporation | 510.14 Million USD | 88.153% |
Sanara MedTech Inc. | 9.11 Million USD | -563.176% |
STAAR Surgical Company | 31.46 Million USD | -92.062% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -20386.78% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 96.635% |
Jin Medical International Ltd. | - USD | -Infinity% |